Daetwyler Holding AG is a leading provider of high-quality, system-critical elastomer components. The company serves premium, regulated markets where materials expertise and co-engineering are essential, with a primary focus on Healthcare and Industrial applications.

• System-Critical Components: Produces rubber and elastomer components that are essential for drug delivery and industrial reliability, creating high switching costs.
• Materials Expertise: Deep knowledge in polymer formulations required for highly regulated healthcare and automotive environments.
• Strategic Partnerships: Long-term supply agreements and co-engineering roles with global pharmaceutical and industrial OEMs.
• Regulated Markets: Strong position in segments with high barriers to entry due to stringent quality and regulatory standards (e.g., EU-GMP Annex 1).

• GLP-1 Ramp: Actively scaling capacity to capture massive demand for injectable biologics, particularly GLP-1 (weight loss) therapies.
• Aluminum Capsule Transition: Captured a growing market in single-serve coffee through a majority stake in Capsul'in, pivoting from plastic to aluminum.
• ForwardNow Program: Launched in December 2024 to optimize the operating model and drive medium-term EBIT margins above 17%.

• Industrial Cyclicality: Sensitivity to the automotive sector (Transportation and Electronics unit) and cautious demand in the Chinese EV market.
• US Market Entry: Execution risk in competing within the US oligopoly for high-value healthcare components.
• Geopolitical Risks: Trade policy uncertainty affecting global manufacturing and supply chains.